Anti-CD19-CAR-T Cells in Relapsed/Refractory B-cell Tumor Patients.

NCT06375161 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

B Cell Malignancies

Interventions

BIOLOGICAL: anti-CD19-CAR-T cells

Sponsor

Shanghai Tongji Hospital, Tongji University School of Medicine